Feb 27 (Reuters) - Allogene Therapeutics Inc:
* ALLOGENE THERAPEUTICS REPORTS FOURTH QUARTER AND FULL YEAR 2019 FINANCIAL RESULTS
* Q4 LOSS PER SHARE $0.58
* Q4 EARNINGS PER SHARE ESTIMATE $-0.69 -- REFINITIV IBES DATA
* ALLOGENE THERAPEUTICS- EXPECTS FY 2020 GAAP NET LOSSES TO BE BETWEEN $260 MILLION AND $280 MILLION Source text for Eikon: Further company coverage:
Our Standards: The Thomson Reuters Trust Principles.